EUROPEAN MARKETS FOR NONVASCULAR STENTS

111 Pages | 27 Exhibits | 2012 Analysis | Forecasts Through 2015 Product Family: Market Reports




OVERVIEW:
In recent years, there have been considerable advances both in product design and materials used for all forms of nonvascular stents. Significant changes in the structure and design of nonvascular stents have been made through proprietary technologies, which have helped prevent stent migration and improve flexibility. In 2010, nonvascular stents (including biliary, esophageal, trachobronchial, and urologic) stents were used in more than 56,550 interventional procedures in the countries covered by this report (France, Germany, Italy, Spain, and the United Kingdom), generating nearly $93 million in associated product sales. Over the forecast period covered by this report, the number of nonvascular stenting procedures performed in Europe is expected to increase at a 3.1% growth rate, reaching nearly 65,790 in the year 2015; during the same period, corresponding dollar sales are expected to increase at a 6.4% growth rate, reaching approximately $126 million in the year 2015.

This new report by Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the European nonvascular stents market. Major topics covered by this report include a discussion of current and emerging nonvascular stenting technologies; a clinical overview of nonvascular conditions targeted by stenting, and an analysis of the European markets for biliary, esophageal, tracheobronchial, and urologic (including ureteral and urethral/prostatic) stents.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Stent Design 
ii. Procedure Volumes
iii. Market Analysis 
	a. Biliary Stents 
	b. Esophageal Stents 
	c. Tracheobronchial Stents 
	d. Urologic Stents 
	e. Combined Market Forecast 

Exhibit ES-1: Europe, Nonvascular Stent Placements, Combined Procedure Volumes Forecast, 2010-2015 
Exhibit ES-2: Europe, Nonvascular Stents, Combined Market Forecast, 2010-2015 

1. CURRENT AND EMERGING PERIPHERAL VASCULAR AND NONVASCULAR STENTING TECHNOLOGIES

1.1 Stent Design 
	1.1.1 Vascular Stents 
	1.1.2 Nonvascular Stents 
	1.1.3 Stent Deployment Mechanisms 
1.2 Stent Materials 
	1.2.1 Metal 
		1.2.1.1 Absorbable Magnesium Alloys 
		1.2.1.2 Cobalt Alloys 
		1.2.1.3 Nickel-Titanium Alloys
		1.2.1.4 Stainless Steel 
	1.2.2 Standard Polymers 
	1.2.3 Biodegradable Polymers 
1.3 Stent Coatings 
	1.3.1 Radiopacity Enhancement 
	1.3.2 Biocompatibility Enhancement 
	1.3.3 Active Therapeutic Enhancement 
		1.3.3.1 Drug-Eluting Stents 
			1.3.3.1.1 Antirestenotic Efficacy 
			1.3.3.1.2 Drug Delivery Techniques 
	1.3.4 Stent Coverings and Linings 

Exhibit 1-1: Selected Biomedical, Clinical, and Technical Stent Requirements 
Exhibit 1-2: Advantages and Disadvantages of Selected Vascular Stent Designs 
Exhibit 1-3: Advantages and Disadvantages of Metal Stent Materials 
Exhibit 1-4: Selected Polymeric Stent Materials 
Exhibit 1-5: Selected Characteristics of Antirestenosis Agents Used in Drug-Eluting Stents 
Exhibit 1-6: Advantages and Disadvantages of Nonresorbable and Biodegradable Polymeric Drug Carriers  for Drug-Eluting Stents 

2. OVERVIEW OF STENTING FOR NONVASCULAR APPLICATIONS

2.1 Bile Duct Diseases 
	2.1.1 Benign Biliary Strictures 
	2.1.2 Malignant Biliary Strictures 
	2.1.3 Treatment 
2.2 Esophageal Diseases 
	2.2.1 Benign Esophageal Strictures 
	2.2.2 Malignant Esophageal Strictures 
	2.2.3 Treatment 
		2.2.3.1 Nonsurgical Treatment 
		2.2.3.2 Surgical Treatment 
2.3 Renal System Diseases 
	2.3.1 Benign Urethral and Prostatic Strictures 
	2.3.2 Malignant Urethral and Prostatic Strictures 
	2.3.3 Treatment 
2.4 Tracheobronchial System Diseases 
	2.4.1 Benign Tracheobronchial Strictures 
	2.4.2 Malignant Tracheobronchial Strictures 
	2.4.3 Treatment 
		2.4.3.1 Expandable Metal Stents 
		2.4.3.2 Silicone Stents 

3. EUROPEAN NONVASCULAR STENTS MARKET

3.1 Biliary Stents 
	3.1.1 Products and Technologies 
	3.1.2 Market Analysis 
	3.1.3 Competitive Analysis 
3.2 Esophageal Stents 
	3.2.1 Products and Technologies 
	3.2.2 Market Analysis 
	3.2.3 Competitive Analysis 
3.3 Tracheobronchial Stents 
	3.3.1 Products and Technologies 
	3.3.2 Market Analysis 
	3.3.3 Competitive Analysis 
3.4 Urologic Stents 
	3.4.1 Products and Technologies 
		3.4.1.1 Ureteral Stents 
		3.4.1.2 Urethral (or Prostatic) Stents 
	3.4.2 Market Analysis 
	3.4.3 Competitive Analysis 
3.5 Combined Market Analysis 
	3.5.1 Market Drivers 
	3.5.2 Market Limiters 
	3.5.3 Combined Market Forecast 

Exhibit 3-1: 2012, Europe, Selected Biliary Stents 
Exhibit 3-2: Europe, Biliary Stent Placements, Procedure Volumes Forecast, 2010-2015 
Exhibit 3-3: Europe, Biliary Stents, Market Forecast, 2010-2015 
Exhibit 3-4: 2010, Europe, Biliary Stents Market, Share by Supplier 
Exhibit 3-5: 2012, Europe, Selected Esophageal Stents 
Exhibit 3-6: Europe, Esophageal Stent Placements, Procedure Volumes Forecast, 2010-2015 
Exhibit 3-7: Europe, Esophageal Stents, Market Forecast, 2010-2015 
Exhibit 3-8: 2010, Europe, Esophageal Stents Market, Share by Supplier 
Exhibit 3-9: Advantages and Disadvantages of Metal and Silicone Tracheobronchial Stents 
Exhibit 3-10: 2012, Europe, Selected Tracheobronchial Stents 
Exhibit 3-11: Europe, Tracheobronchial Stent Placements, Procedure Volumes Forecast, 2010-2015 
Exhibit 3-12: Europe, Tracheobronchial Stents, Market Forecast, 2010-2015 
Exhibit 3-13: 2010, Europe, Tracheobronchial Stents Market,  Share by Supplier 
Exhibit 3-14: 2012, Europe, Selected Urologic Stents 
Exhibit 3-15: Europe, Urologic Stent Placements, Procedure Volumes Forecast, 2010-2015 
Exhibit 3-16: Europe, Urologic Stents, Market Forecast, 2010-2015 
Exhibit 3-17: 2010, Europe, Urologic Stents Market, Share by Supplier 
Exhibit 3-18: Europe, Nonvascular Stent Placements, Combined Procedure Volumes Forecast, 2010-2015 
Exhibit 3-19: Europe, Nonvascular Stents, Combined Market Forecast, 2010-2015 

4. COMPANY PROFILES

4.1 Abbott Laboratories 
4.2 C.R. Bard, Inc. 
4.3 Boston Scientific Corporation 
4.4 Cook Group, Inc. 
4.5 ev3, Inc./Covidien, Inc. 
4.6 W.L. Gore & Associates, Inc. 
4.7 Johnson & Johnson 
4.8 Medtronic, Inc. 

APPENDIX:  COMPANY LISTING


COMPANIES COVERED:

  1. Abbott Laboratories
  2. Allium Medical Solutions LTD
  3. American Medical Systems, Inc.
  4. C.R. Bard, Inc.
  5. Boston Scientific Corporation
  6. Cook Medical/Cook Group, Inc.
  7. Cook Group, Inc.
  8. Cordis Corporation/ Johnson & Johnson
  9. Covidien PLC
  10. ELLA-CS SRO
  11. ev3, Inc./Covidien PLC
  12. W.L. Gore & Associates, Inc.
  13. Johnson & Johnson
  14. Medtronic, Inc.
  15. Merit Endotek/ Merit Medical Systems, Inc.
  16. endotek.merit.com
  17. M.I. Tech Co., LTD
  18. Novatech/bess AG
  19. OptiMed Medizinische Instrumente GmbH
  20. Pnn Medical AS
  21. RUSCH/Teleflex, Inc.
  22. Stentech, Inc.
  23. Taewoong Medical Co., LTD
Contact Us

Need help finding medtech research? Let us help you!